APA (7th ed.) Citation

Zhou, D., Wang, Y., Ning, W., & Chen, C. (2024). Comparison of primary and metastatic site‐related PD‐L1 expression in predicting ORR in patients with advanced NSCLC who received ICB‐based therapy. Thoracic Cancer, 15(5), 379. https://doi.org/10.1111/1759-7714.15201

Chicago Style (17th ed.) Citation

Zhou, Danhong, Yang Wang, Weiwei Ning, and Cheng Chen. "Comparison of Primary and Metastatic Site‐related PD‐L1 Expression in Predicting ORR in Patients with Advanced NSCLC Who Received ICB‐based Therapy." Thoracic Cancer 15, no. 5 (2024): 379. https://doi.org/10.1111/1759-7714.15201.

MLA (9th ed.) Citation

Zhou, Danhong, et al. "Comparison of Primary and Metastatic Site‐related PD‐L1 Expression in Predicting ORR in Patients with Advanced NSCLC Who Received ICB‐based Therapy." Thoracic Cancer, vol. 15, no. 5, 2024, p. 379, https://doi.org/10.1111/1759-7714.15201.